Biodistribution and tumor imaging of an anti-CEA single-chain antibody-albumin fusion protein

Nuclear Medicine and Biology

Volumn 35, Issue 2, 2008, Pages 151-158

  Yazaki, Paul J ^a   Kassa, Thewodros ^a   Cheung, Chia wei ^a   Crow, Desiree M ^a   Sherman, Mark A ^a   Bading, James R ^a   Anderson, Anne Line J ^a   Colcher, David ^a   Raubitschek, Andrew ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Albumin fusion protein; CEA; Colorectal cancer; Imaging

Indexed keywords

ALBUMIN ANTIBODY; HYBRID PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BIOACCUMULATION; COLORECTAL CARCINOMA; DIAGNOSTIC IMAGING; FEMALE; HUMAN; HUMAN CELL; ISOTOPE LABELING; MOUSE; NONHUMAN; NUDE MOUSE; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; XENOGRAFT;

ALBUMINS; ANIMALS; ANTIBODIES, NEOPLASM; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOCONJUGATES; IMMUNOGLOBULIN VARIABLE REGION; INDIUM RADIOISOTOPES; IODINE RADIOISOTOPES; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; POSITRON-EMISSION TOMOGRAPHY; RADIOIMMUNODETECTION; RADIOPHARMACEUTICALS; RECOMBINANT FUSION PROTEINS; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 38849143822     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2007.10.010     Document Type: Article

References (23)

1. Chuang V.T., Kragh-Hansen U., and Otagiri M. Pharmaceutical strategies utilizing recombinant human serum albumin. Pharm Res 19 (2002) 569-577
2. Smith B.J., Popplewell A., Athwal D., Chapman A.P., Heywood S., West S.M., et al. Prolonged in vivo residence times of antibody fragments associated with albumin. Bioconjug Chem 12 (2001) 750-756
3. Huhalov A., and Chester K.A. Engineered single chain antibody fragments for radioimmunotherapy. Q J Nucl Med Mol Imaging 48 (2004) 279-288
4. Dennis M.S., Zhang M., Meng Y.G., Kadkhodayan M., Kirchhofer D., Combs D., et al. Albumin binding as a general strategy for improving the pharmacokinetics of proteins. J Biol Chem 277 (2002) 35035-35043
5. Dennis M.S., Jin H., Dugger D., Yang R., McFarland L., Ogasawara A., et al. Imaging tumors with an albumin-binding Fab, a novel tumor-targeting agent. Cancer Res 67 (2007) 254-261
6. Orlova A., Tolmachev V., Pehrson R., Lindborg M., Tran T., Sandstrom M., et al. Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors. Cancer Res 67 (2007) 2178-2186
7. Wu A.M., and Yazaki P.J. Designer genes: recombinant antibody fragments for biological imaging. Q J Nucl Med 44 (2000) 268-283
8. Wu A.M., Chen W., Raubitschek A., Williams L.E., Neumaier M., Fischer R., et al. Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers. Immunotechnology 2 (1996) 21-36
9. Wong J.Y., Chu D.Z., Williams L.E., Yamauchi D.M., Ikle D.N., Kwok C.S., et al. Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancer. Clin Cancer Res 15 (2004) 5014-5021
10. Yazaki P.J., Wu A.M., Tsai S.-W., Williams L., Ikle D.N., Wong J.Y.C., et al. Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and T84.66 minibody: Comparison to radioiodinated fragments. Bioconj Chem 12 (2001) 220-228
11. Peter Jr. T. All about albumin: biochemistry, genetics and medical applications (1996), Academic Press, San Diego (CA)
12. Anderson C.L., Chaudhury C., Kim J., Bronson C.L., Wani M.A., and Mohanty S. Perspective - FcRn transports albumin: relevance to immunology and medicine. Trends Immunol 27 (2006) 343-348
13. Wu A.M. Engineering multivalent antibody fragments for in vivo targeting. Methods Mol Biol 248 (2004) 209-225
14. Carmichael J.A., Power B.E., Garrett T.P., Yazaki P.J., Shively J.E., Raubitschek A.A., et al. The crystal structure of an anti-CEA scFv diabody assembled from T84.66 scFvs in V(L)-to-V(H) orientation: implications for diabody flexibility. J Mol Biol 326 (2003) 341-351
15. Sugio S., Kashima A., Mochizuki S., Noda M., and Kobayashi K. Crystal structure of human serum albumin at 2.5 A resolution. Protein Eng 12 (1999) 439-446
16. Horton R.M., Hunt H.D., Ho S.N., Pullen J.K., and Pease L.R. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77 (1989) 61-68
17. Yazaki P.J., and Wu A.M. Expression of recombinant antibodies in mammalian cell lines. Methods Mol Biol 248 (2004) 255-268
18. Qi J., and Leahy R.M. Resolution and noise properties of MAP reconstruction for fully 3-D PET. IEEE Trans Med Imaging 19 (2000) 493-506
19. Adams G.P., Schier R., McCall A.M., Simmons H.H., Horak E.M., Alpaugh R.K., et al. High affinity restricts the localization and tumor penetration of single-chain Fv antibody molecules. Cancer Res 61 (2001) 4750-4755
20. Tanaka T., Shiramoto S., Miyashita M., Fujishima Y., and Kaneo Y. Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME). Int J Pharm 277 (2004) 39-61
21. Wang J., Ueno H., Masuko T., and Hashimoto Y. Binding of serum albumin on tumor cells and characterization of the albumin binding protein. J Biochem (Tokyo) 115 (1994) 898-903
22. Wu A.M., Williams L.E., Zieran L., Padma A., Sherman M.A., Bebb G.G., et al. Anti-carcinoembryonic antigen (CEA) diabody for rapid tumor targeting and imaging. Tumor Targeting 4 (1999) 47-58
23. Yazaki P.J., Sherman M.A., Shively J.E., Ikle D., Williams L.E., Wong J.Y.C., et al. Humanization of the anti-CEA T84.66 antibody based on crystal structure data. Protein Eng Des Sel 17 (2004) 481-489